Apollo Hospitals Enterprise growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+15.8%+14.9%
EBITDA+24.8%+22.5%
Net Income+33.1%+33.3%
EPS (adj.)+34.3%+33.3%
Total Assets+7.5%+15.4%
Total Equity+15.3%+15.2%
Free Cash Flow+111.0%+53.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

APOLLOHOSP₹8,137.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.17L Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+15.8+14.9
EBITDA+24.8+22.5
Net Income+33.1+33.3
EPS (adj.)+34.3+33.3
Total Assets+7.5+15.4
Total Equity+15.3+15.2
Free Cash Flow+111.0+53.2
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 145%.